In this presentation given at Asia Pharma in March 2010, Christopher Ung, VP Strategic Business and Operations, Oncology at Quintiles discusses Tissue Biomarkers & Digital Pathology in Oncology Clinical Development.

In it, he evaluates solutions for better understanding compounds, specifically focusing on tissue based biomarkers and mutations such as EGFR and KRAS and the solutions Quintiles offers through our global network of anatomic pathology laboratories located in the United States, United Kingdom, China and Singapore.